Lawrenson K - Search Results

1

Src as a novel therapeutic target for endometriosis.

Lawrenson K, Lee N, Torres HA, Lee JM, Brueggmann D, Rao PN, Noushmehr H, Gayther SA. Lawrenson K, et al. Gynecol Oncol. 2014 Oct;135(1):100-7. doi: 10.1016/j.ygyno.2014.06.016. Epub 2014 Jun 24. Gynecol Oncol. 2014. PMID: 24972189

2

MYBL2 Drives Prostate Cancer Plasticity: Inhibiting Its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate Cancer.

German B, Alaiwi SA, Ho KL, Nanda JS, Fonseca MA, Burkhart DL, Sheahan AV, Bergom HE, Morel KL, Beltran H, Hwang JH, Freedman ML, Lawrenson K, Ellis L. German B, et al. Among authors: lawrenson k. Cancer Res Commun. 2024 Sep 1;4(9):2295-2307. doi: 10.1158/2767-9764.CRC-24-0069. Cancer Res Commun. 2024. PMID: 39113611 Free PMC article.

3

Rewiring of master transcription factor cistromes during high-grade serous ovarian cancer development.

Nameki RA, Chang H, Yu P, Abbasi F, Lin X, Reddy J, Haro M, Fonseca MA, Freedman ML, Drapkin R, Corona RI, Lawrenson K. Nameki RA, et al. Among authors: lawrenson k. bioRxiv [Preprint]. 2023 Apr 12:2023.04.11.536378. doi: 10.1101/2023.04.11.536378. bioRxiv. 2023. PMID: 37090516 Free PMC article. Preprint.

4

Ovarian cancer: a clinical challenge that needs some basic answers.

Lawrenson K, Gayther SA. Lawrenson K, et al. PLoS Med. 2009 Feb 3;6(2):e25. doi: 10.1371/journal.pmed.1000025. PLoS Med. 2009. PMID: 19192945 Free PMC article.

5

In vitro three-dimensional modelling of human ovarian surface epithelial cells.

Lawrenson K, Benjamin E, Turmaine M, Jacobs I, Gayther S, Dafou D. Lawrenson K, et al. Cell Prolif. 2009 Jun;42(3):385-93. doi: 10.1111/j.1365-2184.2009.00604.x. Epub 2009 Apr 24. Cell Prolif. 2009. PMID: 19397591 Free PMC article.

6

Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer.

Lawrenson K, Grun B, Benjamin E, Jacobs IJ, Dafou D, Gayther SA. Lawrenson K, et al. Neoplasia. 2010 Apr;12(4):317-25. doi: 10.1593/neo.91948. Neoplasia. 2010. PMID: 20360942 Free PMC article.

7

Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers.

Dafou D, Grun B, Sinclair J, Lawrenson K, Benjamin EC, Hogdall E, Kruger-Kjaer S, Christensen L, Sowter HM, Al-Attar A, Edmondson R, Darby S, Berchuck A, Laird PW, Pearce CL, Ramus SJ, Jacobs IJ, Gayther SA. Dafou D, et al. Among authors: lawrenson k. Neoplasia. 2010 Jul;12(7):579-89. doi: 10.1593/neo.10340. Neoplasia. 2010. PMID: 20651987 Free PMC article.

8

Modelling genetic and clinical heterogeneity in epithelial ovarian cancers.

Lawrenson K, Sproul D, Grun B, Notaridou M, Benjamin E, Jacobs IJ, Dafou D, Sims AH, Gayther SA. Lawrenson K, et al. Carcinogenesis. 2011 Oct;32(10):1540-9. doi: 10.1093/carcin/bgr140. Epub 2011 Aug 22. Carcinogenesis. 2011. PMID: 21859834

9

Heterotypic three-dimensional in vitro modeling of stromal-epithelial interactions during ovarian cancer initiation and progression.

Lawrenson K, Grun B, Gayther SA. Lawrenson K, et al. J Vis Exp. 2012 Aug 28;(66):e4206. doi: 10.3791/4206. J Vis Exp. 2012. PMID: 22951414 Free PMC article.

10

A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro.

Lee JM, Mhawech-Fauceglia P, Lee N, Parsanian LC, Lin YG, Gayther SA, Lawrenson K. Lee JM, et al. Among authors: lawrenson k. Lab Invest. 2013 May;93(5):528-42. doi: 10.1038/labinvest.2013.41. Epub 2013 Mar 4. Lab Invest. 2013. PMID: 23459371 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters